| Literature DB >> 24353832 |
Yosra Belaïd-Nouira1, Hayfa Bakhta1, Zohra Haouas1, Imen Flehi-Slim1, Hassen Ben Cheikh1.
Abstract
Despite the reports on safety concerns regarding the relationship between aluminum salts and neurological and bone disease, many countries continue to use aluminum as phosphate binders among patients with renal failure. In search for a diet supplement that could reduce aluminum toxicity related to renal failure, we carried out this prospective animal study in which the fenugreek seeds were assessed for their effects on rats nephrotoxicity induced by aluminum chloride (AlCl3). Oral AlCl3 administration during 5 months (500 mg/kg bw i.g for one month then 1600 ppm via drinking water) led to plasma biochemical changes, an inhibition of alkaline phosphatase (ALP), a decrease of total antioxidant status (TAS), and an induction of lipid peroxidation (LPO) in the blood and brain, in addition to kidney atrophy and morphological alterations at the level of Bowman's capsule, the glomerulus and different sorts of tubules, reminiscent of some known kidney disease. The treatment with the whole fenugreek seed powder (FSP) (5% in the diet) during the last 2 months showed its effectiveness in restoring normal plasma values of urea, creatinine, ALP and glucose, as well as re-increasing the TAS, inhibiting LPO and alleviating histopathological changes in the injured kidneys. This study highlights the induced nephrotoxicicity, as well as the related toxicity in the brain and bone, by chronic oral ingestion of the aluminum salts. However, the maintenance of a diet supplemented with fenugreek seeds could offer protection for the kidney, bone and brain, at the same time.Entities:
Keywords: Aluminum; Trigonella foenum-graecum; rat; renal insufficiency
Year: 2013 PMID: 24353832 PMCID: PMC3865269 DOI: 10.4162/nrp.2013.7.6.466
Source DB: PubMed Journal: Nutr Res Pract ISSN: 1976-1457 Impact factor: 1.926
Composition of the standard diet
aCasein represents 86.3% protein
bMineral mixture contained the following (mg/kg of diet): CaHPO4, 17200; KCl, 4000; NaCl, 4000; MgO, 420; MgSO4, 2000; Fe2O3, 120; FeSO4 · 7H2O, 200; trace elements, 400 (MnSO4 · H2O, 98; CuSO4 · 5H2O, 20; ZnSO4 · 7H2O, 80; CoSO4 · 7H2O, 0.16; KI, 0.32; sufficient starch to bring to 40 g [per kilogram of diet]).
cVitamin mixture contained the following (milligrams per kilogram of diet): retinol, 12; cholecalciferol, 0.125; thiamine, 40; riboflavin, 30; pantothenic acid, 140; pyridoxine, 20; inositol, 300; cyanocobalamine, 0.1; menadione, 80; nicotinic acid, 200; choline, 2720; folic acid, 10; p-aminobenzoic acid, 100; biotin, 0.6; sufficient starch to bring to 20 g (per kilo gram of diet).
Effect of FSP on body weight and kidney weight in rats treated with AlCl3
Values are expressed as means ± SD; n = 10 for each treatment group.
1)NS, no statistically significant difference at α = 0.05 by ANOVA-test
Different superscript letter means significant difference between groups at α = 0.05 by ANOVA-test
Effects of FSP on plasma markers in rats treated with AlCl3
Values are expressed as means ± SD; n = 10 for each treatment group.
Different superscript letter means significantly different between groups at α = 0.05 by ANOVA-test
Urea, creatinine, LDH, ALP, glucose are expressed respectively as: mmol/L, µmol/L, UI/L, UI/L, mmol/L.
Fig. 1Effect of FSP on LDH levels in plasma, brain and liver of AlCl Values are expressed as means ± SD; n = 10 for each treatment group. Different letters above each bar indicate significant differences among groups at α = 0.05 by ANOVA test.
Fig. 2Effect of FSP on TAS in plasma and brain of AlCl Values are expressed as means ± SD; n = 10 for each treatment group. Different letters above each bar indicate significant differences among groups at α = 0.05 by ANOVA test.
Fig. 3Effect of FSP on TBARS levels in plasma, brain and liver AlCl Values are expressed as means ± SD; n = 10 for each treatment group. Different letters above each bar indicate significant differences among groups at α = 0.05 by ANOVA test.
Fig. 4Light micrographs of rat kidney cortex (a, b, c) and medulla (d, e, f). Control (a, d), AlCl3-treated group (b,e) and Fenugreek + AlCl3-treated group (c, f). (a): a normal aspect of kidney cortex. (b) swelling of both distal and proximal tubules (short arrow), degeneration of cells in the lining epithelium of convoluted tubules with a partial replacement of their simple cuboidal epithelium by a simple squamous one (dotted arrow) and the disappearance of Bowman's spaces in almost all glomeruli (long arrow). (c)(d) normal aspect of the medulla. (e) retraction of the cuboidal epithelial cells which become squamous in both collecting ducts and ascendant thick segments of the loops of Henle (solid arrow), pyknotic nuclei (intensely basophilic) are observed in the collecting duct epithelium along with the loss of cytoplasm definition (dotted arrow). (f) a partial restoration of the cuboidal form of different tubules epithelium, the retrieval of Bowman's spaces and the decrease of pyknotic cells. (×320, hematoxylin-eosin staining)
Fig. 5Light micrographs of PAS staining of rat kidney tissue. Control (a), AlCl3-treated group (b) and Fenugreek + AlCl3-treated group (c). (a) normal cross-section through the convoluted tubules of the cortex. (b) decrease in the brush border density which disappeared in some points leading to a swelling aspect of the proximal tubules (solid arrow) and discontinuity in tubules basement membrane (dotted arrow). (c) a clear restitution of the brush border density as well as the continuity of tubules basement membrane. (×1000)
Fig. 6Light micrographs of Silver nitrate staining of rat kidney tissue. Control (a), AlCl3-treated group (b) and Fenugreek + AlCl3-treated group (c). (a) normal collagenous structures. (b) complete disappearance of Bowman's spaces (solid arrow), thinning in the tubules basement membrane which disappears sometimes (dotted arrow) and a fading of silver staining in the glomeruli. (c) normal aspect of collagenous structures. (×1000)